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The molecular mechanisms of endothelial differentiation into a functional vascular network are incompletely
understood. To identify novel factors in endothelial development, we used a microarray screen with differen-
tiating embryonic stem (ES) cells that identified the gene for ankyrin repeat and SOCS box protein 4 (ASB4)
as the most highly differentially expressed gene in the vascular lineage during early differentiation. Like other
SOCS box-containing proteins, ASB4 is the substrate recognition molecule of an elongin B/elongin C/cullin/
Roc ubiquitin ligase complex that mediates the ubiquitination and degradation of substrate protein(s). High
levels of ASB4 expression in the embryonic vasculature coincide with drastic increases in oxygen tension as
placental blood flow is initiated. However, as vessels mature and oxygen levels stabilize, ASB4 expression is
quickly downregulated, suggesting that ASB4 may function to modulate an endothelium-specific response to
increasing oxygen tension. Consistent with the hypothesis that ASB4 function is regulated by oxygen concen-
tration, ASB4 interacts with the factor inhibiting HIF1 (FIH) and is a substrate for FIH-mediated hydroxy-
lation via an oxygen-dependent mechanism. Additionally, overexpression of ASB4 in ES cells promotes dif-
ferentiation into the vascular lineage in an oxygen-dependent manner. We postulate that hydroxylation of
ASB4 in normoxia promotes binding to and degradation of substrate protein(s) to modulate vascular
differentiation.
Members of the suppressor of cytokine signaling (SOCS)
superfamily are E3 ubiquitin ligase components that contain a
C-terminal SOCS box and an N-terminal protein-protein bind-
ing domain (21, 22). The SOCS box mediates interactions with
an elongin B/elongin C/cullin 5/Roc protein complex to con-
stitute a functional E3 ubiquitin ligase complex (19), while the
N-terminal protein-protein binding domains recruit substrate
proteins to mediate substrate polyubiquitination and protea-
some-mediated degradation. In this way, SOCS proteins confer
substrate specificity on the E3 ubiquitin ligase complex and are
thus tightly regulated at both the transcriptional and posttrans-
lational levels in order to carefully control the steady-state
levels of substrate proteins.
Ankyrin repeat (AR) and SOCS box proteins (ASBs) con-
stitute one subclass of the SOCS superfamily and are charac-
terized by variable numbers of N-terminal ARs as substrate-
binding domains (reviewed in reference 13). To date, at least
18 family members have been identified in mammals and pre-
liminary functional characterization is currently under way. So
far, ASB proteins have been suggested to mediate the ubiq-
uitination of a broad range of target proteins, including tumor
necrosis factor receptor II (ASB3) (2), creatine kinase B
(ASB9) (5), and adaptor protein with PH and SH2 domains
(APS, ASB6) (47). Since ARs function as generic scaffolds for
the creation of modular binding sites that mediate interactions
with an almost unlimited variety of binding motifs and domains
(33, 43), it is not surprising that ASBs interact with and pro-
mote the degradation of a wide diversity of target substrate
proteins.
Our previous data suggest that ASB4, a poorly characterized
member of this family, is highly differentially expressed in the
vascular lineage during development (46). Vasculogenesis, or
the de novo differentiation of pluripotent stem cells into the
vascular lineage during development, is the first stage of blood
vessel formation. Vasculogenesis begins shortly after gastrula-
tion in the developing embryo, as cells with vasculogenic po-
tential have been isolated from the primitive-streak region in
embryonic day 6.5 (E6.5) mouse embryos (14). These cells,
termed hemangioblasts, derive from mesoderm, express
brachyury (also referred to as T) and Flk1, and have both
vascular potential and hematopoietic potential. Primitive cap-
illary plexi of endothelial cells arise from Flk1-positive popu-
lations and are then remodeled in a process similar to that of
adult angiogenesis to yield mature lumenized vessels.
A complex combination of genetically preprogrammed mo-
lecular signals and external environmental cues are responsible
for proper vascular development and remodeling, and an im-
portant role of oxygen tension in these processes has recently
been discovered. The current understanding of the cellular
response to oxygen tension centers around the hypoxia-induc-
ible factor (HIF) family of transcription factors, whose steady-
state levels and activity vary inversely with the oxygen concen-
tration (reviewed in references 24, 30, and 39). The factor
inhibiting HIF1 (FIH) and the prolyl hydroxylase enzymes
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(PHDs) catalyze the hydroxylation of the HIF1 and HIF2
subunits on asparagine and proline residues, respectively. FIH-
mediated HIF hydroxylation disrupts binding to the transcrip-
tional coactivator p300 and results in decreased transcriptional
activity, whereas PHD hydroxylation promotes the binding of
von Hippel-Lindau (VHL) protein, a SOCS protein that me-
diates HIF polyubiquitination and proteasomal degradation
through an elongin B/elongin C/Cul2/Roc1 complex. Since
these hydroxylation reactions are oxygen dependent, decreases
in oxygen concentration (hypoxia) result in (i) disruption of
VHL binding to and degradation of HIF, leading to accumu-
lation of HIF levels, and (ii) promotion of p300 binding, lead-
ing to an increase in HIF transcriptional activity.
Although the exact mechanism is under debate, the oxygen-
dependent effects of FIH on HIF activity suggest that it acts as
a cellular “oxygen sensor” that is important in the transduction
of environmental hypoxic cues into appropriate cellular signals
such as HIF-mediated upregulation of glycolytic and angio-
genic genes (32, 37). Nevertheless, the list of bona fide hy-
droxylation targets of FIH is limited. In the present report, we
demonstrate that ASB4 is expressed during vascular develop-
ment in a window of time during which oxygen tensions are
rapidly changing, is a direct target for FIH-dependent hydroxy-
lation, and promotes differentiation into the vascular lineage in
an oxygen-dependent manner.
MATERIALS AND METHODS
Plasmids. Flag-tagged mouse ASB4 in pEF1 and Flag-tagged mouse ASB1 in
pEF1 were generous gifts from W. Alexander. All PCR amplimers for cloning
were TA cloned, sequenced for accuracy, and (unless otherwise noted) sub-
cloned into destination vectors as N-terminally tagged mouse sequences. All
amino acid locations refer to accession no. NP_075535. For the constructs used,
along with the destination vectors and primer pairs, see Table S1 in the supple-
mental material. Internal deletion mutants and point mutants were generated
with the QuikChange mutagenesis system (Stratagene) with Flag-ASB4 in
pCMV as the template; for the primers used, see Table S1 in the supplemental
material (since primers are reverse complements of each other, only one primer
per pair is listed). pGBKT7, pGADT7, pGBKT7-p53, and pGADT7-T were from
Clontech. To generate Flag-ASB4- and Flag-ASB4SOCS-encoding adenovi-
ruses, PCR-produced, Xba-flanked inserts were subcloned into the XbaI site of
pAdTrack-CMV. All adenoviruses coexpressed cytomegalovirus promoter-driven
green fluorescent protein (GFP).
Antibodies. Antibodies against FIH (NB 100-428; Novus), Flag (F1804;
Sigma), myc (sc-789; Santa Cruz), Cul2 (gift from Y. Xiong) (36), Cul5 (gift from
Y. Xiong; raised against the peptide SNLLKNKGSLQFEDK), elongin B (sc-
1558; Santa Cruz), Roc1 (gift from Y. Xiong) (36), and ubiquitin (MMS-258R;
Covance) were used for immunoblotting. Flag-agarose beads (A2220; Sigma)
and myc-agarose beads (sc-40 ac; Santa Cruz) were used for immunoprecipi-
tation.
Cell culture and transfection conditions. Embryonic stem (ES) cell culture,
differentiation, and fluorescence-activated cell sorter (FACS) analysis have been
described previously (34). Normoxic cultures were performed under atmospheric
oxygen tension (21%) and 5% CO2. Hypoxia culture was at 1% O2 and 5%
CO2. HEK-293T cells were used in all transfection experiments with Fugene 6
reagent (Roche). RNA interference (RNAi) experiments used Dharmafect I
(Dharmacon) and prevalidated small interfering RNA (siRNA) duplexes. Cells
were incubated for 24 h before lysis. For generation of ASB4 stable ES cells,
3Flag-ASB4 in p3xflag-CMV10 (Sigma) was linearized and electroporated into
R1 ES cells, which were selected with 250 g/ml G418 for 14 days. Selective
clones were picked, amplified, and confirmed by anti-Flag immunoblotting.
COS7 cells were used for adenoviral infection.
Microarray analysis. Purification and amplification of total RNA from ES
cells, reverse transcription, and microarray techniques have been described pre-
viously (46). For this analysis, the data set was subjected to supervised hier-
archical clustering with only genes demonstrating a 1.5-fold absolute mean
difference in 84-h Flk1 cells from embryoid bodies. Median centered genes
and arrays were clustered with Cluster (version 2.11; http://rana.lbl.gov
/EisenSoftware.htm), and heat maps of cluster analyses were visualized with
JavaTreeView (version 1.0.12; release date, 14 March 2005; http://sourceforge.net
/projects/jtreeview/).
Reverse transcriptase PCR (RT-PCR) analysis. Total RNA was isolated with
the RNeasy system (QIAGEN). RNA was reverse transcribed with SuperScript
II RT (Invitrogen) using the following oligo(dT) primers: ASB4 PCR, forward
primer 5GAGACACCCCTGCACACGGCAG and reverse primer 5CTCAG
GCTGTGCAGCAGGACGC; glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
forward primer 5ACCACAGTCCATGCCATCAC and reverse primer 5TCC
ACCACCCTGTTGCTGTA.
For real-time PCR analysis, total RNA was reverse transcribed with the iScript
system (Bio-Rad) and a mixture of oligo(dT) and random hexamer primers.
Real-time PCRs were performed with the ABI PRISM 7900 sequence detection
system, software, and reagents. The following prevalidated primer and probe sets
based on Taqman chemistry (Applied Biosystems) were used: Flk1 (accession no.
mM01222419_m1), PECAM (accession no. mM00476702_m1), VE-cadherin
(accession no. mM00486938_m1), Tie2 (accession no. mM01256892_m1), Gata1
(accession no. mM00484678_m1), Klf1 (accession no. mM00516096_m1), Scl/Tal
(mM00441665_m1), and brachyury (accession no. mM00436877_m1). Triplicate
reaction mixtures with independent RNA samples were prepared. RNA input
was calibrated with 18S expression levels, and relative mRNA levels were nor-
malized to levels from empty-vector-transfected, undifferentiated ES cells.
Whole-mount in situ hybridization. Whole-mount in situ hybridization on
mouse embryos has been previously described (34). A 900-bp template for ASB4
probe preparation was prepared with forward primer 5TATCCATGGTGGAC
GGCATCACTGCCCCTATC and reverse primer 5CTCAGGCTGTGCAGCA
GGACGC) and TA cloned into the pCRIItopo vector (Invitrogen). Digoxigenin-
labeled single-strand sense and antisense RNA probes were prepared with the
digoxigenin (DIG) RNA labeling system (Roche).
RNA isolation and Northern blot analysis. Tissues of CD1 embryos and
C57BL/6 adult mice were homogenized and used to prepare total RNA (RNeasy
system; QIAGEN). Northern blot analysis has been described previously (34). A
400-bp ASB4 probe was amplified with forward primers 5GAGACACCCCTG
CACACGGCAG and reverse primer 5CTCAGGCTGTGCAGCAGGACGC,
TA cloned into vector pCR2.1 (Invitrogen), digested with EcoRI, gel purified,
and used as the template for radioactive double-stranded random-primed probe
synthesis (Stratagene).
Immunoprecipitation and immunoblot analysis. Immunoprecipitation and
immunoblotting procedures have been described previously (28). Unless other-
wise noted, cells were lysed in buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl,
1% Triton X-100, 1 Complete protease inhibitor cocktail [Roche]). One mil-
ligram of protein lysate was incubated with 30 l of Flag- or myc-conjugated
beads overnight at 4°C. Beads were washed four times with a 20 volume of
lysis buffer, boiled in 30 l of 2 sodium dodecyl sulfate loading buffer contain-
ing 	-mercaptoethanol for 5 min, and loaded onto 10% protein gels. After
electrophoresis, gels were transferred to polyvinylidene difluoride membranes
and immunoblotted.
Yeast two-hybrid assay. Yeast two-hybrid screens for ASB4 binding partners
were performed with Matchmaker 2-Hybrid system 2 (Clontech) as previously
described (28). ASB4SOCS/GAL4 DNA-binding domain in vector pGBKT7
was transformed into AH109 yeast cells as bait, mated with pretransformed
cDNA library-containing Y187 yeast (HY4042AH; Clontech), and spread onto
agar plates lacking Trp, Leu, His, and Ade for high-stringency selection. To
reconfirm interactions, both ASB4SOCS in pGBKT7 and prey constructs were
cotransfected in various combinations with empty vectors (EVs) as negative
controls and pGBKT7-p53/pGADT7-T vectors as a positive interaction control.
Molecular model development. A fragment of mouse ASB4 spanning AR6 and
-7 (V201 through A288) was used to query various fold recognition servers,
including FUGUE (http://tardis.nibio.go.jp/fugue/prfsearch.html), INUB (http:
//inub.cse.buffalo.edu/), and PHYRE (http://www.sbg.bio.ic.ac.uk/phyre/). Sev-
eral AR-containing protein crystal structures were identified as possessing folds
similar to the mouse ASB4 fragment query. Homologous regions of three crystal
structures were used as templates for model prediction, (i) PYK2-associated
protein beta (PDB accession no. 1DCQ), (ii) Bcl-3 (PDB accession no. 1K1A),
and (iii) the Drosophila Notch receptor (PDB accession no. 1OT8). Models of
the ASB4 ARs were built, guided by the alignments returned from the fold
recognition servers, with the Modeler module of the InsightII molecular mod-
eling system from Accelrys Inc. (www.accelrys.com).
Mass spectrometry (MS). Immunoprecipitates of Flag-ASB4-infected COS7
cells were loaded onto protein gels and stained with Coomassie brilliant blue,
and the bands of interest were cut and processed according to the previously
published protocols from the University of North Carolina-Duke Michael
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Hooker Proteomics Center (38). Peptide digests were analyzed on an ABI 4700
proteomic analyzer by matrix-assisted laser desorption ionization–time of flight
(MALDI-TOF; Applied Biosystems, Inc., Foster City, CA), and the identity of
the protein was confirmed by searching the MS results as outlined previously
(38). Following protein identification, the peptide mixtures were respotted and
the peptide (m/z 1,345.67) corresponding to the hydroxylated ASB4 peptide (m/z
1,329.68) was analyzed by tandem MS (MS/MS) along with the unhydroxylated
peptide. For determination of peptide peak ratios, the curve areas of the m/z
1,329.68 and m/z 1,345.66 peptide peaks, relative to the curve area of the m/z
1,512.823 peptide peak (shown by MS/MS in all samples to be derived from
ASB4), were determined.
RESULTS
ASB4 is expressed in the vascular lineage of differentiating
ES cells. In order to identify genes important during vascular
development, we performed a set of experiments that com-
pared the gene expression profiles of Flk1 and Flk1
 cells
isolated during different stages of differentiating ES cells (de-
scribed by Wang et al. [46]). Out of 20,000 genes, ASB4 was
the most highly differentially expressed gene in Flk1 cells,
compared to Flk1
 cells, at early time points of differentiation
(Fig. 1A). This differential expression was confirmed by RT-
PCR analysis showing that ASB4 mRNA is highly enriched in
the Flk1 population at 84 h, 95 h, and 192 h of differentiation
but is undetectable at 72 h of differentiation (before Flk1 is
expressed in this system) (Fig. 1B). Since Flk1 is expressed in
early precursor cells of the endothelial, hematopoietic, vascu-
lar smooth muscle, and cardiomyocyte lineages (20), we rea-
soned that ASB4 could be important during cardio- and/or
hematovascular development. In support of this, supervised
FIG. 1. ASB4 is highly differentially expressed in the vascular lineage during ES cell differentiation (Diff). (A) Supervised hierarchical cluster
of genes with a 1.5-fold absolute mean difference in 84-h Flk1 cells from embryoid bodies. The Flk1 cluster containing ASB4 is shown at the
right. This experiment was described in detail by Wang et al. (46), and the complete data set is available online through the Gene Expression
Omnibus (series record GSE3757, http://www.ncbi.nlm.nih.gov/geo) and through the University of North Carolina Microarray Database (http:
//genome.unc.edu). Experiments were performed in quadruplicate. (B) RT-PCR analysis of ASB4 expression levels in Flk1 cells from differen-
tiated embryoid bodies. GAPDH was used as a loading control. US, unsorted.
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hierarchical clustering analysis with only genes demonstrating
a 1.5-fold absolute mean fold difference in 84-h Flk1 cells
showed that ASB4 clusters closely with other genes known to
be important in cardiovascular development, including Flk1,
fibronectin, Gata2, and Gata4 (Fig. 1A).
The SOCS box-containing protein ASB4 assembles with a
ubiquitin ligase complex. Since other SOCS box-containing
proteins function as substrate adaptor proteins for elongin
B/elongin C/cullin/Roc ubiquitin ligase complexes by binding
the complex in a SOCS box-dependent manner, we investi-
gated whether ASB4 exists in such complexes and can function
as a ubiquitin ligase. In transient transfection assays with HEK-
293T cells, Flag-ASB4, but not the EV or a mutant lacking the
C-terminal SOCS box (SOCS), coprecipitated endogenous
elongin B, Cul5, Roc1, and to a lesser extent Cul2 (Fig. 2A).
The signal for coprecipitation of Cul2 was greatly increased
with lysates from COS7 cells infected with Flag-ASB4 adeno-
virus (Fig. 2B), indicating that ASB4 can use Cul2 or Cul5
complexes and that this preference is dependent upon the
cellular context. Given that other ASBs associate with Cul5/
Roc1 and Cul5/Roc2 complexes, further studies are needed to
determine if the Cul2 interaction is unique to ASB4 or inher-
ent to all ASBs in the appropriate context and if ASB4 function
is affected by the cullin complex used. Notably, VHL associates
with Cul2, suggesting that ASB4 may share molecular mecha-
nisms with VHL (5, 12, 18, 23).
To evaluate whether ASB4 functions as part of a ubiquitin
ligase complex, in vivo ubiquitination assays were performed.
HEK-293T cells were transfected with Flag-ASB4 for 20 h,
followed by treatment with the proteasome inhibitor MG-132
to allow polyubiquitin-tagged protein accumulation. Flag-
tagged immunoprecipitates were then immunoblotted with anti-
Flag and antiubiquitin antibodies. Strong ubiquitin immu-
noreactivity was detected in Flag-tagged immunoprecipitates
FIG. 2. ASB4 associates with a ubiquitin ligase complex. (A) HEK-293T cells were transfected with Flag-ASB4, Flag-ASB4SOCS (flag-
SOCS), or the EV pCMV. Lysates were immunoprecipitated (IP) with anti-Flag–agarose beads and subjected to immunoblotting (IB) with
anti-Flag, -Cul2, -Cul5, -elongin B, and -Roc1 antibodies. Asterisks denote nonspecific bands. (B) COS7 cells were infected with Flag-ASB4
adenovirus or GFP-alone adenovirus (GFP). Lysates were immunoprecipitated and immunoblotted as described for panel A. (C) HEK-293T cells
were transfected with Flag-ASB4, cultured for 20 h, and then treated with the proteasome inhibitor MG-132 at 40 M for 4 h before protein
harvesting. Lysates were immunoprecipitated as described for panel A and immunoblotted with antiubiquitin (ub) and anti-Flag antibodies.
(D) HEK-293T cells were cotransfected with Flag-ASB4 and myc-ASB4, immunoprecipitated with anti-myc agarose beads, and immunoblotted.
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of Flag-ASB4-transfected cells after MG-132 treatment (Fig.
2C, part 1). We reasoned that this signal could represent ubiq-
uitinated ASB4-associated proteins, ubiquitinated ASB4 itself,
or both. A 7-kDa Flag-tagged immunoreactive laddering pat-
tern was detected in Flag-tagged immunoprecipitates after
treatment with MG-132, indicating that ASB4 itself is ubiquiti-
nated (Fig. 2C, part 2). Furthermore, Flag-ASB4 coprecipi-
tates with myc-ASB4 in cotransfected HEK-293T cells, indi-
cating that ASB4 complexes with itself (Fig. 2D). Since
additional coimmunoprecipitation experiments with HEK-
293T cells did not indicate that substrates are stably associated
with ASB4 in this cell type (data not shown), these data indi-
cate that ASB4 is most likely autoubiquitinated (which may
represent a mechanism of self-regulation) and thus behaves
like a ubiquitin ligase in this system.
ASB4 is expressed in the embryonic vasculature during a
narrow time window. To determine that ASB4 expression is
high in anatomic locations known to harbor active vascular
development and remodeling and to further define exactly
which tissue(s) ASB4 expression is confined to, we analyzed its
expression in embryonic and adult tissues. Global ASB4
mRNA expression is comparatively low in E7.5 embryos but
quickly increases until E9.5 (Fig. 3A). Highly vasculogenic
tissues such as the allantois, yolk sac, and placenta all express
high levels of ASB4. However, while ASB4 expression in the
adult is highest in the testis, ovary, and heart, it is undetectable
in highly vascular organs such as the lung, kidney, and liver
(Fig. 3B), suggesting that ASB4 function may be critical to
proper vascular development but dispensable for the mainte-
nance of adult vessels in some tissues. Furthermore, tissues
containing high numbers of hematopoietic cells such as those
of the spleen and bone marrow have undetectable levels of
ASB4 mRNA expression.
To further define the anatomic location of ASB4 expression
during embryogenesis, we performed whole-mount in situ hy-
bridization analysis with DIG-labeled ASB4 antisense ribo-
probes on mouse embryos at various gestational stages. In E9.5
embryos, ASB4 is expressed in the intersomitic vessels, dorsal
aorta, forelimb buds, allantois/umbilical vessels, vitelline ves-
sels, septum transversum, proepicardium, capillary plexi of the
head and branchial arches, endocardium, and yolk sac vascu-
lature (Fig. 4A, B, D, G, and H). In E10.5 embryos, areas with
high ASB4 expression levels include the forelimb and hind
limb buds, intersomitic vessels, peripheral liver cells, and um-
bilical vessels (Fig. 4E and I). In E11.5 embryos, high levels of
ASB4 expression are limited to the forelimbs and hind limbs
and the most caudal (and most recently formed) intersomitic
vessels (Fig. 4F). Notably, E7.5 embryos show no remarkable
ASB4 staining (data not shown). Analysis with sense probes
confirmed the specificity of the antisense signal (Fig. 4C).
The most striking recurring pattern of ASB4 embryonic ex-
pression is its high levels in primitive capillary plexi, followed
by downregulation as vessels mature. At E9.5, ASB4 is highly
expressed in the capillary plexi of the head and branchial
arches (Fig. 4B), but by E10.5 expression in these vascular beds
is no longer detectable (Fig. 4E). Similarly, ASB4 expression is
high in intersomitic vessels at E10.5 but by E11.5 is confined to
only the most caudal (and thus recently formed) intersomitic
vessels (Fig. 4F). This pattern is recapitulated in the placenta,
with high ASB4 expression in the immature placenta at E9.5
compared to the mature placenta at E13.5 (Fig. 3A). Finally,
ASB4 expression is undetectable in highly vascularized adult
organs such as the kidney and lung (Fig. 3B). This dynamic
temporal regulation of ASB4 expression suggests that its func-
tion is temporally limited. Notably, the endothelium is exposed
to drastic increases in oxygen tension between E9.5 and E10.5
as the placenta develops and maternal-fetal blood gas exchange is
initiated. Since another SOCS box-containing protein, VHL, is
known to regulate the cellular response to changing oxygen
concentrations and since ASB4 may share molecular mecha-
nisms with VHL, we postulated that ASB4 may function during
development in an oxygen-dependent manner to modulate an
endothelium-specific oxygen response during a time at which
oxygen tension drastically increases.
ASB4 binds to FIH by using a conserved motif. As a first
step in the mechanistic characterization of ASB4, we at-
tempted to identify ASB4 binding partners with the yeast two-
hybrid system. We used an ASB4 mutant lacking the C-termi-
nal SOCS box (ASB4SOCS) as bait to avoid reconfirmation
of interactions with known SOCS box binding partners elongin
B and elongin C. With a human heart oligo(dT)-primed pre-
transformed yeast library, we screened more than 1.5  107
independent clones and identified FIH as an interacting pro-
tein under stringent conditions (positive clones grew on plates
lacking tryptophan, leucine, histidine, and adenine). The FIH
prey clone encoded all but the five most N-terminal amino
acids of the human FIH protein. This interaction was con-
firmed in a wheel assay in which yeast cells were transformed
with various combinations of ASB4SOCS bait, FIH prey,
EVs (V1, V2), or mismatched nonspecific controls (Fig. 5A).
p53- and T-antigen (T)-containing plasmids were used as pos-
itive controls for an interaction in this system. Flag-tagged
immunoprecipitates of HEK-293T cells overexpressing Flag-
ASB4 but not Flag-ASB1 coimmunoprecipitated endogenous
FIG. 3. ASB4 mRNA expression in embryonic and adult tissues.
(A) Northern blot analysis of ASB4 expression levels in whole embryos
and dissected extraembryonic tissues. (B) Northern blot analysis of
ASB4 expression levels in adult tissues. BM, bone marrow. Ethidium
bromide staining of 28S rRNA was used as a loading control.
VOL. 27, 2007 ASB4 IN VASCULAR DEVELOPMENT 6411
FIG. 4. Localization of ASB4 mRNA during mouse embryogenesis. Whole-mount in situ hybridization with DIG-labeled RNA probes for
ASB4 was performed on E9.5 to E11.5 mouse embryos. (A) E9.5 embryo. Arrow, allantois; arrowhead, forelimb; bar, 500 m. (B) E9.5 embryo
at high magnification. Arrow, rostral capillary plexus; arrowheads, branchial arch capillary plexi; bar, 50 m. (C) E9.5 embryo probed with sense
probe as a negative control. Bar, 500 m. (D) E9.5 yolk sac. Arrows, yolk sac vessels; bar, 750 m. (E) E10.5 embryo. Arrow, umbilical vessels;
bar, 800 m. (F) E11.5 embryo. Arrow, caudal intersomitic vessels; bar, 1 mm. (G) Transverse section of E9.5 embryo heart. Arrow, endocardium;
arrowheads, dorsal aorta and intersomitic vessel; bar, 80 m. (H) Sagittal section of E9.5 embryo heart. v, ventricle; arrow, pro-epicardium/septum
transversum. (I) Transverse section of E10.5 embryo liver. HL, hind limb; FL, forelimb; arrow, liver; arrowhead, umbilical vessels; bar, 150 m.
(J) Schematic of section location in panels G and I. Antisense probes were used for all images except that in panel C (sense probe). Purple staining
denotes a positive signal. In some cases (G, H, and I), stained whole embryos were paraffin embedded and sectioned for microscopic examination.
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FIH, confirming the specificity of this interaction in mamma-
lian cells (Fig. 5B).
FIH is an asparagine hydroxylase that is known to hydrox-
ylate at least four proteins, HIF1, HIF2 (27) IB, and the
NF-B precursor protein p105 (3). Since the hydroxyl group is
derived directly from atmospheric dioxygen, this reaction is
oxygen dependent and thus FIH is often referred to as a
cellular “oxygen sensor.” This raised the intriguing possibility
that ASB4 is a hydroxylation substrate of FIH and may there-
fore be regulated by atmospheric oxygen tension. FIH has been
shown to bind to and hydroxylate its substrates on the 	 carbon
of a leucine-flanked asparagine residue within ARs (3). The
flanking leucines bind first to position the asparagine for op-
timal binding in the FIH catalytic cleft via a process called
“induced fit” (7). Sequence alignment of ASB4 with four other
known FIH substrates revealed a conserved leucine-flanked
asparagine in AR6 (Fig. 5C). This alignment also indicates
highly conserved residues surrounding the asparagine, includ-
ing perfect conservation of Val 245. Notably, all of these res-
idues (leucines, valine, and asparagine) have previously been
shown to be involved in FIH-substrate interactions (29). To
test whether AR6 is necessary for interaction with FIH, a
variety of N-terminally Flag-tagged mutants were generated
that sequentially lack different domains of the ASB4 protein
(Fig. 5D). Since the hydrophobic interactions between helices
of adjacent ARs are crucial for proper folding, we carefully
FIG. 5. ASB4 binds to FIH through a conserved motif in AR6. (A) Yeast wheel assay. Yeast cells transformed with different combinations of
bait (ASB4SOCS) and prey (FIH) constructs were spread onto a high-stringency selective plate lacking tryptophan, leucine, histidine, and
adenine. p53 and T were used as positive controls. V1, empty bait vector (pGBKT7). V2, empty prey vector (pGADT7). (B) HEK-293T cells were
transfected with either Flag-ASB4 or Flag-ASB1. Lysates were immunoprecipitated (IP) with Flag antibody-conjugated agarose beads and
immunoblotted (IB) with anti-Flag and anti-FIH antibodies. (C) Sequence alignment of mouse ASB4 and other known FIH hydroxylation
substrates. The consensus sequence shows high conservation of E244, V245, N246, A247, and flanking leucine residues. Residue numbers are
indicated above the ASB4 sequence. (D) Schematic of ASB4 with the N-terminal variable region (NTV), nine tandem ARs (poorly conserved
repeats are indicated by parentheses), and a C-terminal SOCS box. Asparagine 246 is contained in the loop of AR6. Schematics of N-terminally
Flag-tagged constructs are denoted below. (E) HEK-293T cells were transfected with Flag-ASB4, Flag-ASB1, and the Flag-ASB4 deletion mutants
described in panel D. Protein lysates were immunoprecipitated with anti-Flag–agarose and immunoblotted with anti-FIH antibody. (F) HEK-293T
cells were transfected with various Flag-ASB4 point mutants and myc-FIH. Lysates were immunoprecipitated with Flag antibody-conjugated
agarose beads and immunoblotted with anti-Flag and anti-myc antibodies. WCL, whole-cell lysate.
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positioned the borders of the deletions in order to best con-
serve the modular structure of the mutants. These mutants
were transiently transfected into HEK-293T cells, Flag immu-
noprecipitated, and immunoblotted with anti-FIH antibody to
detect coprecipitating endogenous FIH protein (Fig. 5E).
ASB4 AR6 and -7 are necessary for interaction with FIH since
mutants lacking either AR6 or -7 were unable to coprecipitate
FIH. Mutants lacking other ARs (AR1, -4, -5, or -8, -9) or the
SOCS box were still able to coprecipitate FIH, indicating that
these domains are dispensable for FIH binding and that dele-
tion of single ARs does not disrupt the tertiary structure of the
FIH-interacting motif.
To test the involvement of the leucine-flanked asparagine
and surrounding residues in FIH binding, we generated a num-
ber of point mutants in and around this motif to test their
involvement in the FIH interaction. Each Flag-tagged point
mutant was transiently transfected with N-terminal myc-FIH,
immunoprecipitated with anti-Flag-conjugated agarose beads,
and immunoblotted with anti-myc antibody to detect copre-
cipitating myc-FIH. Consistent with the “induced fit” model,
point mutation of any of the flanking leucines to aspartate
residues (L238D, L239D, and L256D) reduced coprecipitating
myc-FIH to undetectable levels (Fig. 5F). Single-point muta-
tion of the asparagine residue (N246A) reduced binding to
undetectable levels, while mutation of the adjacent glutamate
(E244A) or valine (V245T) residue reduced but did not abolish
binding. Mutation of the EVN residues to ATA abolished
binding to undetectable levels. Taken together, these data in-
dicate that ASB4 binds to FIH through a conserved hydroxy-
lation motif in AR6 and suggest that ASB4 may be a novel FIH
hydroxylation substrate.
We also tested the alternative hypothesis that ASB4 inhibits
FIH activity either by ubiquitin-mediated proteasomal degra-
dation or by enzymatic blockade via a competitive binding
mechanism. We found that ASB4 has no effect on FIH ubiq-
uitination and that overexpression of ASB4 does not result in
the activation of HIF-responsive luciferase reporter genes or in
the upregulation of multiple HIF target genes in endothelial
cell lines (data not shown).
ASB4 is hydroxylated on asparagine 246 by an oxygen-de-
pendent mechanism. To determine if the leucine-flanked as-
paragine is positioned in an appropriate conformation to allow
binding to and hydroxylation by FIH, we generated a structural
model of ASB4 AR6 and -7 (Fig. 6A). This model shows that
the asparagine and flanking leucine residues of ASB4 are op-
timally positioned to allow an induced fit of the asparagine into
the catalytic cleft of FIH and prompted further studies to
examine the possibility of FIH-mediated ASB4 hydroxylation.
To test the hypothesis that ASB4 is an FIH hydroxylation
substrate, adenovirus-overexpressed Flag-ASB4 was Flag im-
munoprecipitated from COS7 cells grown under normoxic cul-
ture conditions, in-gel trypsinized, and analyzed by MALDI-
TOF MS. The predicted mass/charge ratio (m/z) of the Asn
246-containing trypsin-digested peptide TLLDNNAEVNAR
is 1,329, and hydroxylation of this peptide will result in a 16-Da
shift to 1,345. By MALDI-TOF analysis, we detected the
1,329-Da peptide and a 1,345-Da peptide that did not match
the predicted m/z value for any of the peptides from trypsin-
digested Flag-ASB4, suggesting that the m/z 1,345 peak repre-
sents the hydroxylated form of the 1,329-Da peptide (Fig. 6B).
This was confirmed through MALDI-TOF-TOF MS/MS se-
quencing analysis of the 1,329- and 1,345-Da peptides, sepa-
rately. Alignment of the MS/MS spectra of the 1,329- and
1,345-Da peptides demonstrates that the 16-Da shift due to
hydroxylation is present only in peptide ions containing Asn
246, indicative of FIH-mediated asparagine hydroxylation of
ASB4 (Fig. 6C).
Under normoxic conditions (21% oxygen), the ratio of un-
hydroxylated to hydroxylated ASB4 peptide is 3.1:1, indicating
that under normoxic conditions, only 25% of ASB4 is hy-
droxylated (Fig. 6D). To test if this was due to saturation of
endogenous FIH enzymatic activity by supraphysiologic con-
centrations of transfected ASB4, we coexpressed ASB4 and
FIH in HEK-293T cells, which resulted in the hydroxylation of
nearly all (89%) of the ASB4. These results emphasize the
importance of the stoichiometric ratio of FIH and its sub-
strates for hydroxylation activity, and further studies that eval-
uate what percentage of endogenous ASB4 is hydroxylated are
needed. To confirm that ASB4 hydroxylation was indeed de-
pendent on endogenous FIH, we cotransfected cells with
siRNA duplexes against either FIH or GAPDH as a negative
control. Immunoblot analysis confirmed the successful knock-
down of FIH, and the percentage of hydroxylated ASB4 in cells
lacking FIH (7%) was threefold less than that in the negative
controls (21%). Since FIH-mediated hydroxylation of known
substrates is O2 dependent (and thus inhibited by hypoxia), we
tested whether hypoxic conditions would decrease ASB4 hy-
droxylation. Importantly, when HEK-293T cells transfected
with Flag-ASB4 were cultured under hypoxic conditions (1%
oxygen), the percentage of hydroxylated ASB4 peptide
dropped to 7%. Similar results were obtained when these cells
were treated with chemical hypoxia mimetics (CoCl2 and
dipyridyl) or hydroxylase inhibitors (dimethyloxalylglycine)
(data not shown). Together, these data demonstrate that FIH
hydroxylates ASB4 at Asn 246 via an oxygen-dependent mech-
anism and suggest that ASB4 function may be regulated by
oxygen concentrations.
We next tested whether ASB4 hydroxylation affects ASB4
stability or autoubiquitination by repeating the in vivo ubiq-
uitination experiments described in Fig. 2 with unhydroxylat-
able mutants (AR6 and EVN3ATA) or coexpression of
FIH. Steady-state levels of ASB4 and levels of autoubiquitina-
tion were not affected by these parameters (data not shown).
ASB4 functions to promote ES cell differentiation into the
vascular lineage in an oxygen-dependent manner. Since we
were unable to identify any effects of ASB4 over- or underex-
pression in multiple cell lines (data not shown) and since other
SOCS family proteins are known to regulate cell differentia-
tion, we investigated the effects of ASB4 overexpression on ES
cell differentiation into the vascular lineage and whether these
effects can be regulated by oxygen concentration.
First, to determine the effects of ASB4 overexpression on
this system, mouse ES cells were electroporated with linearized
3Flag-tagged ASB4, the unhydroxylatable ASB4 AR6 and
EVN3ATA mutants, or the p3Xflag-CMV EV and placed in
G418 to select for stable transfected clones. (We also at-
tempted RNAi-mediated knockdown of ASB4 with six differ-
ent short hairpin RNA sequences from integrated lentivirus
constructs but were unable to attain greater than 40% silencing
[data not shown], indicating that the ASB4 transcript may be
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FIG. 6. ASB4 is hydroxylated on asparagine 246 by an oxygen-dependent mechanism. (A) Structural model of ASB4 AR6 and -7 (yellow ribbon
backbone) positioned above the FIH (gray stick backbone)/HIF peptide (purple ribbon backbone) crystal structure (PDB accession no. 1H2K).
Space-filled EVNA residues are colored orange. Space-filled FIH residues contributing to HIF binding are colored yellow. Leucines and other
possible hydrophobic interacting residues are colored blue. (B) COS7 cells were infected with Flag-ASB4 adenovirus for 24 h. Lysates were
immunoprecipitated with Flag antibody-conjugated agarose beads. Beads were eluted with Flag-tagged peptide and subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and Coomassie staining. Flag-ASB4 bands were subjected to in-gel trypsin digestion and MALDI-TOF
MS analysis. The 1,329-Da peak represents the unhydroxylated form of the asparagine-containing peptide, and the 1,345-Da peak (asterisk)
represents the hydroxylated form of the peptide. (C) The 1,329- and 1,345-Da peptides were analyzed by MS/MS. A 16-Da shift was observed with
the y4-y8 ions but not with the y2 ions, consistent with hydroxylation at the asparagine residue. (D) HEK-293T cells transiently transfected with
Flag-ASB4 were cotransfected with myc-FIH or siRNA targeting FIH or GAPDH (negative control) or cultured under hypoxic conditions (1%).
Flag-ASB4 protein was isolated and analyzed as for panel B, and the peak area ratio of unhydroxylated (1,329 Da) to hydroxylated (1,345 Da)
peptide was calculated to evaluate the percentage of hydroxylated ASB4. In parallel, whole-cell lysates were subjected to immunoblotting (IB) by
FIH antibody. Asterisks indicate nonspecific bands.
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FIG. 7. ASB4 overexpression in ES cells increases the percentage of Flk1 cells and vascular commitment via an oxygen-dependent mechanism.
ES cells were electroporated with constructs encoding cytomegalovirus promoter-driven 3Flag-ASB4, unhydroxylatable ASB4 mutants (AR6
and EVN3ATA), or the vector alone (EV), and stably expressing clones were selected for by culture in G418 for 14 days. Positive clones were
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inherently resistant to RNAi-mediated downregulation.) After
14 days, surviving colonies were picked and expanded and
expression was confirmed by immunoblotting. Multiple clones
were chosen for initial experiments to control for nonspecific
effects due to random integration. Upon differentiation, ASB4-
expressing clones, but not unhydroxylatable mutants, demon-
strated a significant increase in Flk1 cells at 96 h of differen-
tiation compared to EV clones (Fig. 7A and B), indicating that
ASB4 expression leads to an expansion of the hematovascular
lineage and that this effect is dependent on the hydroxylated
Asn 246 in AR6. To examine the causes of this Flk1 cell
increase and to investigate the ramifications of this increase for
downstream lineage commitment, real-time RT-PCR analysis
was performed with stage- and lineage-restricted genes. Since
Flk1 cells arise from mesoderm cells during differentiation,
we investigated the overall levels of brachyury (T) expression
as a marker for mesoderm. At day 4 of differentiation,
brachyury levels were slightly, but significantly, increased in
ASB4-expressing clones, suggesting increased mesodermal
commitment (Fig. 7C). Since Flk1 cells are progenitors for
both hematopoietic and vascular cells in this system, we
investigated the global expression levels of a variety of he-
matopoietic (Gata1, Scl/Tal) and vascular (Tie2, VE-cad-
herin) markers. All of these markers were tested at time
points representing the peak of their expression in this sys-
tem (day 6 for hematopoietic markers, day 8 for vascular
makers). Interestingly, compared to EV clones, ASB4-ex-
pressing clones exhibited increased expression of vascular
markers and decreased expression of hematopoietic markers,
suggesting that enforced expression of ASB4 causes preferen-
tial commitment of stem cells to the vascular lineage (Fig. 7C).
Together, these data suggest that ASB4 induces the formation
of vascular precursors from mesoderm and promotes commit-
ment to the vascular lineage.
On the basis of our hypothesis that ASB4 is likely to be
regulated by oxygen concentration, we predicted that its effects
on vascular lineage commitment are oxygen dependent. To test
this hypothesis, we differentiated the stably transfected ES cells
described above under hypoxic conditions (1% atmospheric
oxygen). The kinetics of differentiation are similar to normoxic
differentiation (data not shown), so the same time points were
used for analysis of lineage-restricted markers. Interestingly,
the differences in the commitment to the Flk1 cell popula-
tion, as well as the expression of hematopoietic and vascular
lineage-specific markers observed with ASB4 overexpression
under normoxic conditions, were completely abrogated by hy-
poxic treatment (Fig. 7D and E), indicating that the ability of
ASB4 to promote the differentiation or maturation of the
endothelial lineage is oxygen dependent and is inhibited by
hypoxia.
DISCUSSION
In the present study, we show for the first time that ASB4 (i)
is a substrate recognition molecule of an E3 ubiquitin ligase
complex, (ii) is highly expressed in the vascular lineage during
development, (iii) functions to promote differentiation and
maturation of the vascular lineage by an oxygen-dependent
mechanism, and (iv) is regulated by FIH-mediated hydroxyla-
tion. These data are consistent with our model in which ASB4
functions in an oxygen-dependent manner in order to promote
endothelial differentiation and/or maturation in response to
increasing oxygen levels during early vascular development.
ASB4 is a member of the SOCS superfamily, whose mem-
bers function as the substrate recognition molecules of a cullin-
based E3 ubiquitin ligase complex. The list of characterized E3
ubiquitin ligase proteins is rapidly expanding, and recent stud-
ies have uncovered a novel role for ubiquitin ligases during
endothelial differentiation and maturation. HIF and Notch
family members are critical for proper vascular development,
especially during endothelial remodeling, and both families are
tightly regulated by ubiquitin-mediated proteasomal degrada-
tion. For example, VHL binds to hydroxylated HIF1 to me-
diate its degradation in an oxygen-dependent manner, while
Fbw7, Numb, Itch, and Mind-bomb all modulate Notch signal-
ing (1, 15–17, 25, 26, 31, 40, 45). Deficiencies of these factors
result in vascular abnormalities, indicating that signal regu-
lation via the ubiquitin-proteasome system is critical for
proper vascular development (10, 11, 44, 45). The endothe-
lium-restricted expression of ASB4 described in this report
further emphasizes the important role of the ubiquitin-pro-
teasome system in modulating endothelial biology during
embryogenesis.
The vascular expression of ASB4 is not only spatially re-
stricted to the primitive endothelium but is also tightly tempo-
rally regulated. ASB4 is maximally expressed in both the em-
bryonic vasculature and the developing placenta from E9.5 to
E10.5 but is then quickly downregulated, demonstrating that
ASB4 function in the vasculature is temporally confined. No-
tably, this brief period of high ASB4 expression coincides with
rapid and drastic changes in embryonic oxygen levels. As the
placenta forms between E9.5 and E10.5, oxygen delivery to
the embryo quickly changes from passive diffusion through the
multiple cell layers of the decidua and the embryo to maternal-
fetal blood gas exchange across thin placental membranes (4).
Intraembryonic oxygen tension quickly rises, and the endothe-
isolated, expanded, and used for differentiation experiments as previously described. (A and B) FACS analysis of 96-h differentiated embryoid
bodies (EBs) shows a drastic increase in Flk1 cells in ASB4-expressing clones but not in clones expressing unhydroxylatable mutants. Results in
panel A are representative of three independent experiments. Results in panel B represent averages of three independent clones in three
independent differentiation experiments. Flk1 cells in ASB4-expressing clones were normalized to EV clones in each experiment. (C) Real-time
RT-PCR analysis of differentiated embryoid bodies was used to determine the lineage commitment of ASB4-expressing ES cells. Compared with
EV cells, 96-h differentiated ASB4-expressing ES cells show increased expression of a marker of mesoderm commitment (brachyury [T]) and of
a marker of early vascular lineage commitment (Flk1). At day 6, ASB4-expressing ES cells show decreased expression of hematopoietic lineage
markers (Gata1, Scl/Tal), and at day 8, they show increased expression of vascular markers (Tie2, VE-cadherin [VE-Cad]). Results represent
averages of three independent biologic replicates. (D and E) Embryoid bodies stably expressing either ASB4 or EV were differentiated under
hypoxic conditions (1% oxygen) and analyzed via FACS and real-time PCR as described for panels B and C.
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lium must transduce these environmental cues into an appro-
priate biologic response. ASB4 is uniquely expressed tempo-
rally and spatially to play a role in the unique response of the
endothelium to changing oxygen concentrations (41). Interest-
ingly, ASB4 is conserved in animals as distant as zebra fish, but
the hydroxylated asparagine is only conserved in animals that
develop within a placenta or an egg. Zebra fish, which develop
externally and thus have less drastic changes in oxygen tension
during development, show no conservation of this region.
Our data indicate that one of the ramifications of ASB4
function is to increase the differentiation and maturation of the
vascular lineage in an oxygen-dependent manner, suggesting
that ASB4 may function to coordinate endothelial differenti-
ation or maturation in the face of changing oxygen levels. This
is especially intriguing considering the role of oxygen concen-
tration on placental vascular development. The allantois,
which has been shown to harbor mesoderm-derived vasculo-
genic cells (6), makes contact with the chorion around E8.5 to
initiate placental vascularization (reviewed in references 4 and
42). During this process, a subset of trophoblast cells migrate
into the uterine wall, proliferate, and differentiate into endo-
thelium-like cytotrophoblast cells that line the maternal blood
vessels to facilitate maternal-fetal blood gas exchange. Oxygen
tension is critical in this process. Early on, hypoxia activates
cytotrophoblast proliferation and invasion of the uterine tis-
sues, but as these cells reach the highly oxygenated maternal
blood vessels, the high oxygen levels inhibit proliferation and
promote their differentiation into an endothelium-like pheno-
type (8, 9). It is interesting that overall ASB4 expression levels
in whole allantoides and placentas are initially high and de-
crease concomitantly with vessel maturation and increasing
oxygen tensions, suggesting that ASB4 may function to mod-
ulate placental cellular differentiation in response to changing
oxygen microenvironments.
ASB4 is hydroxylated by FIH, which provides a mechanism
for the ASB4-mediated oxygen-dependent modulation of vas-
cular differentiation or maturation. The hydroxylation activity
of FIH is known to be proportional to the oxygen concentra-
tion, and in this way, ASB4 hydroxylation may be an early step
in the transduction of environmental oxygen cues to appropri-
ate biological responses. Since hydroxylation has been shown
to affect protein-protein interactions between the SOCS family
member VHL and its ubiquitination substrate HIF1, and
since we were unable to detect any differences in ASB4 ex-
pression, subcellular localization, or autoubiquitination under
hypoxic conditions (data not shown), we predict that the func-
tional ramification of ASB4 hydroxylation is to modulate ASB4
binding to and degradation of substrate protein(s). Until re-
cently, the only known intracellular hydroxylated proteins were
HIF1 and HIF2 subunits and it was thus supposed that the
cellular response to hypoxia was largely dependent upon HIF-
mediated transcriptional upregulation of hypoxia response
genes such as those for VEGF and GLUT-1 (3, 32). However,
our data indicate that ASB4 is a member of a currently limited
number of non-HIF FIH hydroxylation substrates and suggest
that the mechanisms of the cellular hypoxic response may be
much broader and more complex than initially suspected.
Whereas HIF1 subunits are responsible for the transcrip-
tional response to hypoxia, ASB4 may represent a major com-
ponent of the cellular posttranslational response to changing
oxygen levels. Compared to transcriptional upregulation, post-
translational ubiquitination is much more rapid and enables a
faster cellular response without the lag time associated with
transcriptional activation and protein synthesis. For example,
the ubiquitin-proteasome system extensively regulates the cell
cycle, a process governed by dynamic changes in protein levels
(35). Thus, oxygen-dependent ubiquitin ligase activity of ASB4
may allow the cell to respond rapidly to the quickly changing
oxygen microenvironments that are found immediately follow-
ing the initiation of placental blood gas exchange. Further-
more, unlike HIF1, which is expressed in nearly all cell types,
cell-specific expression of hydroxylated proteins such as ASB4
allows cell type-specific responses to changing oxygen levels. In
this case, ASB4 may function to initiate rapid endothelial dif-
ferentiation in response to quickly rising oxygen tensions dur-
ing development. These data provide new insights into the
mechanistic complexity of oxygen sensing in mammalian cells
and suggest that endothelial and other cell types may mount
unique responses to changing oxygen tensions during develop-
ment through oxygen-dependent modulation of the ubiquitin-
proteasome system.
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